Investors
Ceretas is a clinical-stage medtech company developing a portable, non-invasive therapeutic ultrasound platform to treat Alzheimer’s disease and other neurodegenerative conditions. Here you will find our ASX announcements, investor presentations, corporate governance documents, and financial disclosures.
ASX Announcements
View all Ceretas (CTS) announcements on the Australian Securities Exchange (ASX).
Results & Reports
Download Ceretas’s quarterly, half-yearly and annual results.
2026
| 31 Aug |
Share Price
Corporate Governance
Ceretas is committed to strong corporate governance and compliance with the ASX Corporate Governance Principles.
Governance Documents
Remuneration and Nomination Committee Charter
Audit and Risk Management Committee Charter
Disclosure and Communication Policy
Share Registry
Shareholders should contact the share registry directly to update shareholder details, manage holdings, or access registry services.
Automic Group
1300 288 644 (within Australia)
+61 2 9698 5414 (outside Australia)
hello@automicgroup.com.au
www.automicgroup.com.au